Gagal Jantung Akut

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 30

GAGAL JANTUNG AKUT

ACUTE HEART FAILURE

dr. Jusdiono, SpJP, FIHA

DEFINISI
New onset or recurrence of gradual of rapidly

worsening signs and symptoms of HF requiring


urgent or emergency treatment
1. Cepat
: Disfungsi Mendadak
2. Preload - Afterload Mismatch
3. Dapat terdapat pada pasien dengan/ tanpa
kelainan jantung sebelumnya (Mis. Transfusi
overload)

3 KOMPONEN GJ
1. Symptomps : Cape / Sesak
2. Signs

: Oedem / Ronchi / Tachycardia


3. Evidence : Cardiomegaly / S3 Gallop /
Murmur / Echo

PATOFISIOLOGI
3 Fase :
1. Fase Inisiasi
2. Fase Amplifikasi
3. Fase Vicious Cycle

PATOFISIOLOGI
Fluid retention
Capillary interstitial fluid exchange ( pulmonary

oedema)
Myocardial pump performance
Extra cardiac pathologies

6 SUBSET KLINIS GJA


1. ADHF ( Acute on chronic )
2. Hypertensive AHF
3. Pulmonary Oedema
4. ACS and HF ( Acute de novo )
5. Cardiogenic Shock
6. Right Heart Failure

ADHF
1. Environmental : Excess salt and fluid (24%)
2. Noncompliance with medication (24%)
3. Adverse medication efforts (16%)
CCB
Antiaritmic
NSAID
Corticosteroids
Alcohol

ADHF
4. Cardiovascular
Acute

Ischemia / Infarction
Pulmonary Embolism
Uncontrolled Hypertension
Aritmia
Worsening of valve disfunction, endocarditis

ADHF
5. Extra Cardiac Illness
Sepsis,

Infection, Hypoxia
Renal Failure
Thyroid Disease
Anemia, Blood loss
Sleep apnea
Bilateral renal artery stenosis

HEMODYNAMIC SUBSET

Cardiac Index
L/min/m2

Warm and Dry

Warm and Wet

Cold and Dry

Cold and Wet

2,2

18
PCWP or LVEDP

HEMODYNAMIC SUBSET
Optimize
Chronic Tx

Cardiac Index
L/min/m2

Warm and Dry

Warm and Wet

Cold and Dry

Cold and Wet

2,2

18
PCWP or LVEDP

HEMODYNAMIC SUBSET
Warm and Dry

Diuretic +/
Adjuvant Tx

Warm and Wet


2,2

Cold and Dry

Cold and Wet

18
PCWP or LVEDP

Cardiac Index
L/min/m2

HEMODYNAMIC SUBSET

Cardiac Index
L/min/m2

Vasodilator
+/ Inotropes

Warm and Dry

Warm and Wet

Cold and Dry

Cold and Wet

2,2

18
PCWP or LVEDP

HEMODYNAMIC SUBSET
Warm and Dry

Warm and Wet


2,2

Cold and Dry

Cold and Wet

18
PCWP or LVEDP

Cardiac Index
L/min/m2
Diuretic +/
Vasodilator +/
Inotropes

Volume Overload

Cardiac
Output

WET

18
PCWP or LVEDP

Symptoms :
Shortness of breath,
Pulmonary congestion,
Peripheral edema,
Jugular venous
distention

Cardiac Output

2,2
Cardiac Index
L/min/m2
COLD

PCWP or LVEDP

Symptoms
Cold,
Clammy
extremities,
Altered mental
status

CLASSIFICATION OF HEART FAILURE


American Heart Association Classification
Stage A : Patients are at high risk for heart failure
but
have not developed structural heart
disease and have no
symptoms
Stage B : Patients have developed structural heart disease
have not (yet) developed symptoms
Stage C : Patients with past or current heart failure
symptoms in association with structural damage
to the
heart
Stage D : Patients with end stage, or terminal heart failure
requiring special treatment strategies

NEW YORK HEART ASSOCIATION CLASIFICATION

Class

Functional State

Symptoms

No limitation

Asymptomatic during
usual daily activity

II

Slight limitation

Mild symptoms
(dyspnea, Fatique, or
chest pain) with ordinary
daily activity

III

Moderate Limitation

Symptoms noted with


minimal activity

IV

Severe Limitation

Symptoms arrest

DIAGNOSTIC STUDIES
Basic Laboratory testing
Screening for cardiac enzymes
B-Natriuretic Peptide
ECG
Chest X-Ray
Echocardiography
Pulmonary artery catheterization
Peak flow / end tidal CO2

ESTABLISH THE DIAGNOSIS


Physical :
Vital sign : Hypertermi (sepsis), hypothermia (thyroid
disease), Bradicardia ( AV block, Hyperkalemia, drug,
severe hypoxia)
Signs of congestion : jugular venous distention,
abdominal jugular reflux, audible 3rd heart sound
Pulmonary , leg exam

VASODILATORS
Vasodilators

Dosing

SE

Other

NTG

10 20 mg/min
200 mg/min

Hypotension
Headache

Tolerance or
continuous use

ISDN

1 mg/hour
10 mg/hour

Hypotension
Headache

Tolerence or
continuous use

Nitroprusside

0,3 mg/kg/min
5 mg/kg/min

Hypotension
Isocyanate
Toxicity

Light Sensitive

INOTROPES
Short term inotropic support maintain systemic

perfusion and preserve end-organ performance


Deleterious effect upon patients with preserved or
moderately depressed ventricular function and
congestion
Not demonstrated improved outcomes

INOTROPES
Debutamine : 2-20 mg/kg/min
2. Dopamin
: <3 mg/kg/min : renal effect
3-5 mg/kg/min : Inotropic effect
>5 mg/kg/min : Vasopressor effect
1.

VASSOPRESSORS
Norepinephrine
: - No bolus
- 0,2 1,0 mg/kg/min
2. Epinephrine
: - Bolus 1mg can be given I.V
during resuscitation, repeated
every 3-5 min
- 0,05 0,5 mg/kg/min
1.

RESPIRATORY THERAPY
CPAP improves

Lung mechanics : recruiting Atelectatic alveoli, Improving


pulmonary compliance, reducing work of breathing
Hemodynamics : reducing preload and afterload

Recommends acute cardiogenic pulmonary edema


Start at 10 15 CmH2O

Mechanical Circulatory Support


Renal Replacement Therapy
IABP ( Intra Aortic Ballon Pump )
Extracorporeal ventricular assist devices
ECMO ( Extra Corporeal Membrane

Oxygenation)

DRUG FOR HEART FAILURE


Proven morbidity and mortality benefit
B Blocker
ACE Inhibitors
ARB
Aldosterone Antagonist
ISDN Hydralazine

DRUG FOR HEART FAILURE


Improved symptoms and no prove mortality benefit
Digoxin
Nexiritide
I.V Vasodilators
Inotropic Agents

TherapyforHeartDisease
Mechanical Support Devices
CRT (cardiac resynchronization therapy )
VADs ( Ventricular Assist Devices)

You might also like